Potential adverse effects of the inhaled corticosteroids.
about
Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion modelAsthma outcomes: biomarkersTreatment with pyranopyran-1, 8-dione attenuates airway responses in cockroach allergen sensitized asthma in miceQuantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysisInhaled corticosteroids in childhood asthma: the story continuesEditorial inhaled corticosteroids: the endocrine and metabolic complications.Inhaled corticosteroids and bone healthInhalational Steroids and Iatrogenic Cushing's SyndromeInhaled corticosteroids and secondary adrenal insufficiencyA self-rating scale for patient-perceived side effects of inhaled corticosteroids.As Needed Use of Inhaled Corticosteroids for Management of Mild Persistent Asthma in Children.Ciclesonide: a novel inhaled corticosteroid.House dust mite allergen avoidance and self-management in allergic patients with asthma: randomised controlled trial.Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.The Childhood Asthma Management Program (CAMP): Contributions to the Understanding of Therapy and the Natural History of Childhood AsthmaPharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids: part 1. Which test should be used?Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)--the risk as determined by gold standard adrenal function tests: a systematic review.Inhaled corticosteroids in lung diseases.Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model.Inhaled corticosteroids in COPD and the risk of serious pneumonia.Comparison of inhaled corticosteroids: an update.Ciclesonide and the treatment of asthma.A review of mometasone furoate / formoterol in the treatment of asthma.Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease.Voice problems in school-aged children following very preterm birth.Benefits and Risks of Long-Term Asthma Management in Children: Where Are We Heading?Mometasone furoate nasal spray for the treatment of asthma.Serum Fructosamine, Total Cholesterol, and High-Density Lipoprotein in Children with Asthma during Glucocorticoid Treatment.Effects of fluticasone propionate dosage in an experimental model of feline asthma.Exhaled nitric oxide: a predictor of steroid response.Hoarseness in asthmatic patients: the side effect of inhaled steroid or not?Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis.Osteoporosis in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome.Effects of inhaled steroids on growth, bone metabolism and adrenal function.Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin).Use and safety of long-acting β2-agonists for pediatric asthmaRisk factors for nonunion of bone fracture in pediatric patients: An inception cohort study of 237,033 fractures
P2860
Q24805892-0B48BB85-358D-4B08-B0DE-5E982E2B0BF2Q30425168-DF1AAC00-B828-42BF-904F-E8332620002BQ31149555-1B8B7620-9599-49BE-B5F2-570DBFBC508BQ34551086-A70000A4-4BDE-4B01-819C-0B9AC87D105FQ34995731-E9933DCB-20A4-427B-A9D6-BCC79CE56196Q35056139-5EB11811-D00A-444A-B916-E759F7ACECD0Q35056142-1D0A865A-AA63-403B-A513-967BCBC8594EQ35056151-447D3065-2394-44A4-85B4-D7199A89777CQ35056188-EDE12D71-BE09-4D55-9B35-B2BD732EC5CAQ35132250-33A7CAFB-2AFC-407E-B856-57B531B6A330Q35761866-15557F3A-6F21-499B-AED4-4A5EEE6F7466Q35906990-3737937F-361F-401C-BA04-92086B419C7DQ36093451-C8F1448E-160E-4AFA-B1A7-6748628F44C2Q36373455-D58FEF11-64BB-4C14-8B2F-455D66176C2EQ36455870-EC1C0D29-CDD0-47F0-87D8-928ACD648C0EQ36538896-8DA7CD41-2BC3-454D-9CDC-79D98AC34B56Q36782563-BC90FFD8-790D-41FE-A9D1-7861E983E9CCQ36846725-78516606-01E8-424F-9157-6862E4571174Q36903071-DBDE4835-1FA5-4C77-B46B-081B4B7A6614Q36999789-B1351E2B-2E4F-42E8-934C-536C2158A718Q37177130-2008095C-8FB7-4E28-9EE8-0E763194C3FDQ37267655-F6F1714D-1B67-4B6C-A619-8698EE9DA958Q37406595-CD83CF3D-A300-422B-A825-92153F59EC08Q37681579-04BE8EC9-2B5D-4797-89E3-AC780D141129Q38077842-3EEB11D9-6146-4544-96EB-5C7A12DC6413Q38306695-0C27455B-73C1-4BAD-9DD8-462642C01639Q38746640-F9C5FB0D-84F1-4BA9-9BAB-1D0B1D1BA453Q38785897-D09932E3-703D-432F-A12C-1C5434FFB6FFQ38842838-F182A957-5162-47C7-BCAF-D2CBC9F0600AQ40848064-2A9F0F1A-57E0-4024-9674-DEB8D5C72FF4Q43300894-6728EC3D-AF15-4969-AE7B-F18CD028C300Q46496987-3AF8F408-6DD4-4B71-8D65-B470291635D5Q46837595-2878A8CF-9B4E-4D31-859C-C2758F9FF35AQ46944618-D89D350C-8EC9-4860-AF1B-7070FD9BB39BQ49758922-ED9DCD0C-8A38-474B-9654-C557D4F7CF39Q50948479-23FC7172-AD35-464E-9BEB-127C05212CA1Q51534835-DB5D518F-C408-4AB8-A800-59353D273C8FQ57821604-286DF6D5-052C-4FD0-A5A8-C2EB5498E728Q58801984-F68C1611-5325-4B84-8AB0-5AD60B4E8DE9
P2860
Potential adverse effects of the inhaled corticosteroids.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Potential adverse effects of the inhaled corticosteroids.
@ast
Potential adverse effects of the inhaled corticosteroids.
@en
type
label
Potential adverse effects of the inhaled corticosteroids.
@ast
Potential adverse effects of the inhaled corticosteroids.
@en
prefLabel
Potential adverse effects of the inhaled corticosteroids.
@ast
Potential adverse effects of the inhaled corticosteroids.
@en
P1476
Potential adverse effects of the inhaled corticosteroids.
@en
P2093
H William Kelly
Harold S Nelson
P304
469-78; quiz 479
P356
10.1016/S0091-6749(03)01870-0
P407
P577
2003-09-01T00:00:00Z